CONFIDENTIAL TREATMENT REQUESTED LICENSE AGREEMENTLicense Agreement • February 22nd, 2019 • Inhibrx, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledFebruary 22nd, 2019 Company Industry JurisdictionThis License Agreement (“Agreement”) is made and entered into as of the 28th day of February 2018, Pacific Standard time (the “Effective Date”) by and between Elpiscience Biopharmaceuticals, Inc., a Cayman Islands company having offices at Offices of Corporate Filing Services Ltd., 3rd Floor, Harbour Centre, George Town, P.O. Box 613, Grand Cayman KY1-1107, Cayman Islands (“Elpiscience”) and Inbrx105 LP (“Inhibrx”), a Delaware limited partnership with an address at 11099 North Torrey Pines Road, Suite 280, La Jolla, CA 92037. Elpiscience and Inhibrx are each referred to herein individually as a “Party” and collectively as the “Parties.”
CONFIDENTIAL TREATMENT REQUESTED LICENSE AGREEMENTLicense Agreement • February 22nd, 2019 • Inhibrx, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledFebruary 22nd, 2019 Company Industry JurisdictionThis License Agreement (“Agreement”) is made and entered into as of the 30th day of April 2018, Pacific Standard time (the “Effective Date”) by and between Elpiscience Biopharmaceuticals, Inc., a Cayman Islands company having offices at Offices of Corporate Filing Services Ltd., 3rd Floor, Harbour Centre, George Town, P.O. Box 613, Grand Cayman KY1-1107, Cayman Islands (“Elpiscience”) and Inhibrx, Inc. (“Inhibrx”), a Delaware limited partnership with an address at 11099 North Torrey Pines Road, Suite 280, La Jolla, CA 92037. Elpiscience and Inhibrx are each referred to herein individually as a “Party” and collectively as the “Parties.”